Altered antigenicity of 'a' determinant variants of hepatitis B virus.
about
Genetic variation of hepatitis B virus and its significance for pathogenesisStructural Basis for Treating Tumor Necrosis Factor (TNF )-associated Diseases with the Therapeutic Antibody InfliximabMolecular mechanisms underlying occult hepatitis B virus infection.Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-UpLocalization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies.Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global populationA novel nucleotide insertion in S gene of hepatitis B virus in a chronic carrier.Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected argentine patient with anti-HBs antibodiesHepatitis B surface antigen variant with multiple mutations in the a determinant in an agammaglobulinemic patient.Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan.Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance.The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigenA novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene.Impaired virion secretion by hepatitis B virus immune escape mutants and its rescue by wild-type envelope proteins or a second-site mutationHepatitis B virus genetic variants: biological properties and clinical implicationsModulation of hepatitis B virus secretion by naturally occurring mutations in the S gene.Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China.Hepatitis B virus S gene escape mutants.Molecular mechanisms underlying HBsAg negativity in occult HBV infection.Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational AnalysisImmunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C.Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosides.Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination.A molecular epidemiological study of the hepatitis B virus in Thailand after 22 years of universal immunization.New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.Universal infant immunization and occult hepatitis B virus infection in children and adolescents: a population-based study.The prevalence of mutations in the major hydrophilic region of the surface antigen of hepatitis B virus varies with subgenotype.Unique surface gene variants of hepatitis B virus isolated from patients in the Philippines.Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapyHepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient.Current aspects of hepatitis B surface antigen mutants in Singapore.Hepatitis B virus transfusion risk in China: proficiency testing for the detection of hepatitis B surface antigen.Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users.Hepatitis B caused by a hepatitis B surface antigen escape mutant.Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine.Occult hepatitis B virus infection in immunized children born to carrier mothers.
P2860
Q26772348-0B279E5F-F10D-4FEB-BAA8-D24641325360Q27676857-971A6342-5210-49DC-8B71-DA0862464475Q27686923-DA288F96-8F23-4DFA-86E2-013B250FC461Q28550333-B5A7E1E7-0E45-4554-9214-ED59E1383F97Q30708343-3D0C8510-1789-4672-A126-F86A76952070Q33594457-1563BC95-A721-499F-B4FF-0FADCB6549C3Q33637292-0808DFD3-F41E-4959-8AD5-FC9929FE3338Q33945175-F84F419E-7FB3-4997-81A1-2B7EFF6763B0Q34269133-C054F01F-1D82-4A53-BA75-B7538D30B47EQ34719636-2220FE2F-6F89-4E90-9BCB-CACEBF90ADB9Q34784288-36F51F5B-C696-4336-9368-DA4FAF78B79FQ35596881-4A505878-B677-4B1B-81F7-975267128528Q35867968-A1D76C94-B97B-4359-9315-EB2C17306918Q36098566-4F814DA2-7BD9-4BBC-A63A-5894A0DA7FF7Q36178345-3AD01F83-4B83-43DC-85F4-14872F6FC079Q36607339-C847FCF9-1E90-45C2-A3A5-0C534F4358BDQ36795324-9F676900-0339-4A14-95C4-20A6049A13C6Q37010025-8749490A-E9CF-4F53-8967-03483DC7D5A2Q37254383-C73A41A8-2B1F-49B4-9FCC-8666CAF5F233Q37936822-3FCC42CE-843B-4049-9CA5-86E2BF27E7ECQ38536404-16DA80A8-5F9F-4150-9AC1-AFE90BD828A7Q39375780-24A74902-280C-4108-8BFB-93CA09BCF3C1Q39548701-9CBDFC7F-22E8-4465-AF92-252D628D8429Q39868517-4ABE23BD-D05E-4905-ACA0-275BEFA5E6C7Q40400203-4283B9E9-8472-4375-A210-301EB9A8FB0CQ40992209-CED43AC4-9356-4F27-9466-E8FD74482C35Q41020199-35DB3C3C-53C5-4327-98B6-ECB3C94F474FQ41454895-A37F28D6-8913-4266-AA72-041DBA800421Q41602121-F32D2468-F85F-4DE2-8576-42A61A1A49B1Q42146321-4AE43FF4-86DF-412D-BA0B-81DBC707DA0AQ42271831-1ED0F362-1DE4-40CE-8196-B978D40B5BAAQ42664710-0F24AAC6-D507-4B7E-B653-16496A75D757Q43895132-E805142D-FD51-4F59-9BC9-52F90B6BB13CQ44100056-A5CFE4CB-B3A4-419D-9738-601BC3D0C642Q44247554-47FD3A2B-66E6-48E5-BCC0-FF0AB0BBE743Q45386657-42D20C16-44BC-4071-B2CA-70733E7DCB24Q45400122-E1C23761-1426-4116-8B88-9AC5C0EE6475Q46676941-1DCA9FA5-F3A4-4F1E-B194-89BB095A6030Q51799050-A9CCD216-88A8-443A-B83B-E7FCA3780AACQ53551944-B790F9C5-8CA8-4109-A7C0-8D6E8B67B361
P2860
Altered antigenicity of 'a' determinant variants of hepatitis B virus.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Altered antigenicity of 'a' determinant variants of hepatitis B virus.
@en
Altered antigenicity of 'a' determinant variants of hepatitis B virus.
@nl
type
label
Altered antigenicity of 'a' determinant variants of hepatitis B virus.
@en
Altered antigenicity of 'a' determinant variants of hepatitis B virus.
@nl
prefLabel
Altered antigenicity of 'a' determinant variants of hepatitis B virus.
@en
Altered antigenicity of 'a' determinant variants of hepatitis B virus.
@nl
P2093
P1476
Altered antigenicity of 'a' determinant variants of hepatitis B virus.
@en
P2093
P304
P356
10.1099/0022-1317-78-10-2639
P407
P478
78 ( Pt 10)
P577
1997-10-01T00:00:00Z